Avastin
Royal_College_calls_for_review_of_bevacizumab_to_treat_AMD_191114
Feb 08
2015
Professor Carrie MacEwen and Professor Andrew Lotery co-author the editorial ‘What is stopping the NHS from using bevacizumab for macular degeneration and other retinal disorders?’, published online on BMJ, calls for UK regulatory bodies to review and appraise use of bevacizumab for use in AMD treatment.
Use of Avastin (bevacizumab) in age related macular degeneration
Dec 30
2014
College statement on the use of Avastin (bevacizumab) in age related macular degeneration December 2014
Use of Anti VEGF agents in children
Dec 29
2014
Statement from the College’s Paediatric Sub-committee; October 2014.